Pfizer and BioNTech said Tuesday that they have initiated a clinical study to assesses the safety and efficacy of a COVID-19 vaccine for adults aged 18 to 55 years that specifically targets the omicron variant of SARS-CoV-2. The study will consist of 1,420 participants in three cohorts, including separate cohorts of people who have received two or three doses of the current Pfizer-BioNTech
A patient with acute myeloid leukemia visited Atrium Health deeply concerned, but not about their disease.They had received a $50,000 bill and had no idea…
Patients with severe alcoholic hepatitis appear more likely to have small intestinal bacterial overgrowth compared with healthy individuals, according to study results published in Cureus.Findings…
SAN FRANCISCO — Patients with asthma and allergic bronchopulmonary aspergillosis experienced improvements with dupilumab, according to data presented at the American Thoracic Society International Conference.Quality…
Colonoscopy prices have increased significantly more at private equity-acquired gastroenterology practices compared with those at independent ones, according to results of a retrospective analysis.However, the…
New restrictions on Covid shots run counter to scientific evidence, the groups said.
The lawsuit argues that the HHS secretary’s withdrawal of public vaccine advice reduces access to vaccines for some people.
In a ward of Nasser hospital in southern Gaza a woman is comforting her crying, 16-month-old granddaughter, one of those affected by what aid workers…
CHICAGO — Despite recent ASCO and FDA guidance recommending the inclusion of people living with HIV in pivotal cancer trials, nearly 75% of trials over…
There’s nothing fancy about tick hunting. When University of Pittsburgh professor Danielle Tufts and her team of public health students go out, they bring just…
NEW YORK — A coalition of doctors’ groups and public health organizations sued the U.S. government on Monday over the decision to stop recommending covid-19…
